TSX:BHC (Bausch Health Companies Inc.)
About BHC
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
Bausch Health Companies Inc. (TSX: BHC) Latest News
Investing
Queue the 2018 Rebound for Valeant Pharmaceuticals Intl Inc.
Investing
Valeant Pharmaceuticals International Inc. Is Trading at 52-Week Highs: Should You Buy or Sell?
Investing
Valeant Pharmaceuticals Intl Inc.’s Recent Debt Offering a Genius Move
Investing
Valeant Pharmaceuticals Intl Inc. Surges ~12% in a Day: Why the Stock Could Easily Double in 2018
Dividend Stocks
New to Investing? Avoid These 5 “Rookie” Mistakes
Investing
Valeant Pharmaceuticals Intl Inc.: The Best Long-Term Rebound Play on the TSX?
Investing
Aurora Cannabis Inc. Surges ~153% in a Month: Can it Catch Up to Canopy Growth Corp.?
Investing
Valeant Pharmaceuticals Intl Inc.: If You’d Bought the Dip, You’re up
Investing
Valeant Pharmaceuticals Intl Inc.: Opportunity or Value Trap?
Investing
Valeant Pharmaceuticals Intl Inc. Is on the Path to Recovery
Investing
Valeant Pharmaceuticals Intl Inc. Gives Back Controversial New Drug